Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Foulks

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cornea|November 15, 2006
What's in a name?Jules Baum, Gary Foulks, Michael A Lemp
Investigative Ophthalmology & Visual Science|January 14, 2011
14-3-3σ controls corneal epithelium homeostasis and wound healingQingxian Lu, Ying Xin, Fei Ye, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 30, 2016
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitisKamran Hosseini, Richard L Lindstrom, Gary Foulks, et al.
Current Eye Research|April 5, 2005
Highly efficient ex vivo gene delivery into human corneal endothelial cells by recombinant adeno-associated virusLi Lai, Ken Lin, Gary Foulks, et al.
Cornea|August 23, 2020
Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled StudiesMichael Korenfeld, Kelly K Nichols, Damien Goldberg, et al.
Investigative Ophthalmology & Visual Science|December 9, 2008
A new model of experimental autoimmune keratoconjunctivitis sicca (KCS) induced in Lewis rat by the autoantigen Klk1b22Guomin Jiang, Yan Ke, Deming Sun, et al.
Investigative Ophthalmology & Visual Science|September 24, 2013
The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on clinical trial design and outcomesGary Foulks, Robin Chalmers, Nancy Keir, et al.
Rheumatic Diseases Clinics of North America|July 20, 2016
New Treatment Guidelines for Sjögren's DiseaseFrederick B Vivino, Steven E Carsons, Gary Foulks, et al.
Annals of the Rheumatic Diseases|November 10, 2020
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trialAlan N Baer, Jacques-Eric Gottenberg, E William St Clair, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cornea|November 15, 2006
What's in a name?Jules Baum, Gary Foulks, Michael A Lemp
Investigative Ophthalmology & Visual Science|January 14, 2011
14-3-3σ controls corneal epithelium homeostasis and wound healingQingxian Lu, Ying Xin, Fei Ye, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 30, 2016
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitisKamran Hosseini, Richard L Lindstrom, Gary Foulks, et al.
Current Eye Research|April 5, 2005
Highly efficient ex vivo gene delivery into human corneal endothelial cells by recombinant adeno-associated virusLi Lai, Ken Lin, Gary Foulks, et al.
Cornea|August 23, 2020
Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled StudiesMichael Korenfeld, Kelly K Nichols, Damien Goldberg, et al.
Investigative Ophthalmology & Visual Science|December 9, 2008
A new model of experimental autoimmune keratoconjunctivitis sicca (KCS) induced in Lewis rat by the autoantigen Klk1b22Guomin Jiang, Yan Ke, Deming Sun, et al.
Investigative Ophthalmology & Visual Science|September 24, 2013
The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on clinical trial design and outcomesGary Foulks, Robin Chalmers, Nancy Keir, et al.
Rheumatic Diseases Clinics of North America|July 20, 2016
New Treatment Guidelines for Sjögren's DiseaseFrederick B Vivino, Steven E Carsons, Gary Foulks, et al.
Annals of the Rheumatic Diseases|November 10, 2020
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trialAlan N Baer, Jacques-Eric Gottenberg, E William St Clair, et al.
Pageof 1